Alpha-adrenergic agonist

Alpha Adrenergic agonist
Drug class

Phenylephrine

Skeletal structor formula of phenylephrine, a common nasal decongestant
Class identifiers
Use Decongestant, Hypotension, Bradycardia, Hypothermia etc.
ATC code N07
Biological target Alpha adrenergic receptors of the α subtype
External links
MeSH D000316

An adrenergic alpha-agonist (or alpha-adrenergic agonists) are a class sympathomimetic agents that selectively stimulates alpha adrenergic receptors. The alpha-adrenergic receptor has two subclasses α1 and α2. Alpha 2 receptors are associated with sympatholytic properties. α Adrenergic agonists have the opposite function of alpha blockers. Alpha adrenoreceptor ligands mimic the action of epinephrine and norepinephrine signaling in the heart, smooth muscle and central nervous system, with norepinephrine being the highest affinity. The activation of α1 stimulates the membrane bound enzyme phospholipase C, and α2 inhibits the enzyme Adenylate cyclase. Inactivation of adenylate cyclase in turn leads to the inactivation of the secondary messenger Cyclic adenosine monophosphate and induces smooth muscle and blood vessel constriction.

Classes

Norepinephrine (noradrenaline)

Although complete selectivity between receptor agonism is rarely achieved, some agents have partial selectivity.

α1 agonist

α1 agonist: stimulates phospholipase C activity. (vasoconstriction and mydriasis; used as vasopressors, nasal decongestants and eye exams). Selected examples are:

α2 agonist

α2 agonist: inhibits adenylyl cyclase activity, reduces brainstem vasomotor center-mediated CNS activation; used as antihypertensive, sedative & treatment of opiate dependence and alcohol withdrawal symptoms). Selected examples are:

Undetermined/unsorted

The following agents are also listed as agonists by MeSH.[4]

Clinical significance

Alpha-adrenergic agonists, more specifically the auto receptors of alpha 2 neurons, are used in the treatment of glaucoma by decreasing the production of aqueous fluid by the ciliary bodies of the eye and also by increasing uveoscleral outflow. Medications such as clonidine target pre-synaptic auto receptors, therefore leading to an overall of decrease in norepinephrine.

See also

References

  1. ↑ Declerck I, Himpens B, Droogmans G, Casteels R (September 1990). "The alpha 1-agonist phenylephrine inhibits voltage-gated Ca2(+)-channels in vascular smooth muscle cells of rabbit ear artery". Pflugers Arch. 417 (1): 117–9. doi:10.1007/BF00370780. PMID 1963492.
  2. ↑ Sagvolden T (2006). "The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD)". Behav Brain Funct. 2: 41. doi:10.1186/1744-9081-2-41. PMC 1764416Freely accessible. PMID 17173664.
  3. ↑ Atalik KE, Sahin AS, Doğan N (April 2000). "Interactions between phenylephrine, clonidine and xylazine in rat and rabbit aortas". Methods Find Exp Clin Pharmacol. 22 (3): 145–7. PMID 10893695.
  4. ↑ MeSH list of agents 82000316

External links

This article is issued from Wikipedia - version of the 11/14/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.